Post
Endpoints News
endpts.com
did:plc:l5aan5lkmuqstilgyczaho3v
Exclusive: A-Alpha Bio, a David Baker spinout, is launching an AI antibody data consortium with GSK, Boltz and others, selling subscription access to the data needed to design antibodies from scratch.
https://endpoints.news/a-alpha-bio-starts-ai-antibody-data-consortium-with-gsk-boltz/?utm_source=Bluesky&utm_medium=organic_social&utm_campaign=editorial&utm_content=
2026-07-21T14:06:20.569Z